Advertisement

Topics

Global Nucleic Acid Testing/NAT Market 2021: US, Europe, JapanSupplier Shares and Strategies, Country Volume and Sales Segment ForecastsInfectious and Genetic Diseases, Cancer, Forensic and Paternity Testing [Report Updated: 27062017] Prices from USD $345

05:30 EDT 1 Jul 2017 | BioPortfolio Report Blog

This unique sevencountry report, 1,398page report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market during this decade.nbsp;

Highlights

Business and technological trends in seven major markets
Five and tenyear test volume and sales forecasts
Market shares of leading competitors
Feature comparison of major analyzers
Profiles of market players and startup firms developing innovative technologies
nbsp;nbsp; and products
Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The NAT market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of costeffective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the NAT market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next ten years.

Geographic Coverage

France
Germany
Italy
Japan
Spain
UK
USA

Worldwide Market Overview

Laboratories performing DNA sequencing andnbsp; NAT
by country and market segment.

Fiveyear test volume and sales projections by country.

Market Segmentation Analysis

Sales and market shares of major suppliers of NAT
reagent kits and components.

Tenyear test volume and sales forecasts for major
applications, including:

Infectious Diseasesnbsp;nbsp;nbsp;nbsp; Forensic Testing
Cancernbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; Paternity Testing/HLA Typing
Genetic Diseasesnbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; Others

Tenyear test volume and sales projections for over 30
NAT assays.

A comprehensive analysis of the sequencing market,
by country and laboratory segment, including:

Industrialnbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; Academic
Governmentnbsp;nbsp; Commercial

Detailed market segmentation analysis, including
review of the market dynamics, trends, structure, size,
growth and major suppliers, by country.

Product/Technology Review

Comparison of leading NAT
analyzers from Abbott, Beckman Coulter, BD, BioRad,
GenProbe, Roche, Tecan and other suppliers.

Extensive review of NAT technologies,
test formats, detection methodologies, trends
in testing automation and over 30 target/signal
amplification methods, including:

PCRnbsp;nbsp;nbsp;nbsp; bDNA
SDAnbsp;nbsp;nbsp;nbsp; NASBA
TMAnbsp;nbsp;nbsp; SSSR, and others
LCR

Worldwide listings of companies, universities and
research centers developing new NAT
technologies and products.

Competitive Assessments

Extensive strategic assessments
of major suppliers and emerging market entrants,
including their sales, product portfolios, marketing
tactics, collaborative arrangements and new technologies/products
in Ramp;D.

Comprehensive listings of companies developing and
marketing NAT products, by test and
application.

Opportunities and Strategic Recommendations

Specific new product development opportunities
with potentially significant market appeal during
the next ten years.

Design criteria for new products.

Alternative market penetration strategies.

Potential market entry barriers and risks.

Business planning issues and concerns.

Methodology

This report is based on a combination of primary and secondary information sources, including interviews with laboratory directors and executives of leading diagnostic companies and startup firms developing innovative technologies and products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearchrsquo;s proprietary data base was conducted.

Contains 1,398 pages and 194 tables

Original Article: Global Nucleic Acid Testing/NAT Market 2021: US, Europe, JapanSupplier Shares and Strategies, Country Volume and Sales Segment ForecastsInfectious and Genetic Diseases, Cancer, Forensic and Paternity Testing [Report Updated: 27062017] Prices from USD $345

NEXT ARTICLE

More From BioPortfolio on "Global Nucleic Acid Testing/NAT Market 2021: US, Europe, JapanSupplier Shares and Strategies, Country Volume and Sales Segment ForecastsInfectious and Genetic Diseases, Cancer, Forensic and Paternity Testing [Report Updated: 27062017] Prices from USD $345"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...